APYX vs CL · rev $48.1M vs P/E 34, rev $20.38B
Apyx Medical Inc (APYX) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
APYX currently screens at market cap $179.6M. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the APYX and CL stock pages for the full models.
Not investment advice.